​

Labcorp Holdings (LH) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

LH Stock Forecast

Labcorp Holdings (LH) stock forecast, based on 35 Wall Street analysts, predicts a 12-month average price target of $315.14, with a high of $342.00 and a low of $290.00. This represents a 21.35% increase from the last price of $259.69.

$150 $190 $230 $270 $310 $350 High: $342 Avg: $315.14 Low: $290 Last Closed Price: $259.69

LH Stock Rating

Labcorp Holdings stock's rating consensus is Buy, based on 35 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 26 Buy (74.29%), 9 Hold (25.71%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 35 0 9 26 Strong Sell Sell Hold Buy Strong Buy

LH Price Target Upside V Benchmarks

TypeNameUpside
StockLabcorp Holdings21.35%
SectorHealthcare Stocks 15.45%

Price Target Trends

1M3M12M
# Anlaysts7811
Avg Price Target$315.14$314.63$306.18
Last Closing Price$259.69$259.69$259.69
Upside/Downside21.35%21.16%17.90%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Oct, 252125--19
Sep, 252125--19
Aug, 252125--19
Jul, 253134--20
Jun, 253134--20
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Oct 29, 2025Kevin CaliendoUBS$320.00$253.7426.11%23.22%
Oct 29, 2025Robert W. Baird$304.00$259.6917.06%17.06%
Oct 28, 2025Michael ChernyLeerink Partners$342.00$261.6330.72%31.70%
Oct 17, 2025UBS$325.00$285.9313.66%25.15%
Oct 17, 2025Ann HynesMizuho Securities$320.00$283.7112.79%23.22%
Oct 14, 2025Truist Financial$320.00$278.4214.93%23.22%
Oct 03, 2025Evercore ISI$305.00$279.449.15%17.45%
Oct 02, 2025Barclays$290.00$279.063.92%11.67%
Aug 25, 2025Robert W. Baird$311.00$276.1112.64%19.76%
Jul 25, 2025Kevin CaliendoUBS$305.00$264.9615.11%17.45%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Oct 28, 2025Leerink PartnersOutperformOutperformhold
Oct 17, 2025UBSBuyBuyhold
Oct 03, 2025Evercore ISIOutperformOutperformhold
Jul 25, 2025UBSBuyBuyhold
Jul 10, 2025HSBCBuyHolddowngrade
Jun 25, 2025BarclaysCautiousCautioushold
May 06, 2025Piper SandlerNeutralNeutralhold
Mar 04, 2025CitigroupNeutralBuyupgrade
Jan 07, 2025Evercore ISIOutperformupgrade
Oct 30, 2024HSBCBuyupgrade

Financial Forecast

EPS Forecast

$0 $5 $10 $15 $20 $25 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28 Dec 29
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28Dec 29
Reported$15.99$24.58$14.04$4.80------
Avg Forecast$18.41$23.84$17.07$13.54$14.52$16.04$17.65$19.56$21.53$21.67
High Forecast$18.41$23.84$17.07$13.64$14.56$16.28$18.43$21.27$21.84$21.98
Low Forecast$18.41$23.84$17.07$13.48$14.45$15.82$16.45$17.16$21.22$21.36
Surprise %-13.15%3.10%-17.75%-64.55%------

Revenue Forecast

$12B $13B $14B $15B $16B $17B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28 Dec 29
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28Dec 29
Reported$13.98B$16.12B$14.88B$12.16B------
Avg Forecast$13.54B$16.01B$14.94B$12.15B$12.99B$13.90B$14.58B$15.40B$16.37B$14.78B
High Forecast$13.54B$16.01B$14.94B$12.16B$13.01B$14.05B$14.86B$15.48B$16.55B$14.94B
Low Forecast$13.54B$16.01B$14.94B$12.14B$12.98B$13.82B$14.25B$15.32B$16.19B$14.61B
Surprise %3.24%0.70%-0.44%0.13%------

Net Income Forecast

$0 $500M $1B $2B $2B $3B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28 Dec 29
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28Dec 29
Reported$1.56B$2.38B$1.28B$418.00M------
Avg Forecast$873.20M$1.89B$1.74B$379.20M$1.22B$1.35B$1.47B$1.62B$1.81B$1.82B
High Forecast$1.15B$2.26B$2.08B$455.04M$1.23B$1.37B$1.55B$1.79B$1.84B$1.85B
Low Forecast$599.01M$1.51B$1.39B$303.36M$1.22B$1.33B$1.39B$1.44B$1.79B$1.80B
Surprise %78.21%25.95%-26.30%10.23%------

LH Forecast FAQ

Is Labcorp Holdings stock a buy?

Labcorp Holdings stock has a consensus rating of Buy, based on 35 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 26 Buy, 9 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Labcorp Holdings is a favorable investment for most analysts.

What is Labcorp Holdings's price target?

Labcorp Holdings's price target, set by 35 Wall Street analysts, averages $315.14 over the next 12 months. The price target range spans from $290 at the low end to $342 at the high end, suggesting a potential 21.35% change from the previous closing price of $259.69.

How does Labcorp Holdings stock forecast compare to its benchmarks?

Labcorp Holdings's stock forecast shows a 21.35% upside, outperforming the average forecast for the healthcare stocks sector (15.45%).

What is the breakdown of analyst ratings for Labcorp Holdings over the past three months?

  • October 2025: 10.53% Strong Buy, 63.16% Buy, 26.32% Hold, 0% Sell, 0% Strong Sell.
  • September 2025: 10.53% Strong Buy, 63.16% Buy, 26.32% Hold, 0% Sell, 0% Strong Sell.
  • August 2025: 10.53% Strong Buy, 63.16% Buy, 26.32% Hold, 0% Sell, 0% Strong Sell.

What is Labcorp Holdings’s EPS forecast?

Labcorp Holdings's average annual EPS forecast for its fiscal year ending in December 2024 is $14.52, marking a 202.50% increase from the reported $4.8 in 2023. Estimates for the following years are $16.04 in 2025, $17.65 in 2026, $19.56 in 2027, $21.53 in 2028, and $21.67 in 2029.

What is Labcorp Holdings’s revenue forecast?

Labcorp Holdings's average annual revenue forecast for its fiscal year ending in December 2024 is $12.99B, reflecting a 6.79% increase from the reported $12.16B in 2023. The forecast for 2025 is $13.9B, followed by $14.58B for 2026, $15.4B for 2027, $16.37B for 2028, and $14.78B for 2029.

What is Labcorp Holdings’s net income forecast?

Labcorp Holdings's net income forecast for the fiscal year ending in December 2024 stands at $1.22B, representing an 192.21% increase from the reported $418M in 2023. Projections indicate $1.35B in 2025, $1.47B in 2026, $1.62B in 2027, $1.81B in 2028, and $1.82B in 2029.